multigene-expression profiles (Xenometrix Inc)
90
Structured Review
Xenometrix Inc
multigene-expression profiles
Multigene Expression Profiles, supplied by Xenometrix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multigene-expression+profiles/multigene+expression+profiles/10__1089_slash_blr__1998__17__788-73-9-28
Average 90 stars, based on 1 article reviews
Multigene Expression Profiles, supplied by Xenometrix Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/multigene-expression+profiles/multigene+expression+profiles/10__1089_slash_blr__1998__17__788-73-9-28
Average 90 stars, based on 1 article reviews
multigene-expression profiles - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
other:Article Title: {BLR 2804} Adenovirus Vectors – Advanced Viral Research Corp. - Amphipathic Peptides – Antibodies - Antinuclear Antibodies – Aquasearch – Australia – Axiom Biotechnologies – Calydon – Cancer – Carbohybrids – Cell Genesys – ChromaXoma – Cocaine – Connective Tissue Diseases – Cyclic Peptides – Demegen – Diabetes – DrugAbuse Sciences – Energy Biosystems – Fibrinogen, Inc. – FISH – Fluorescent Dyes – Gene Activation – Gene Expression Profiling – Gene Therapy – GeneMedicine – Growth Factors – Harvard – Hong Kong – Immunomedics – Interleukin – IntraBiotics – Ixion – Japan – LaJolla Pharmaceutical – Maxim Pharmaceuticals – Myriad Genetics – Nucleotide Sequencing – Onyx – Osiris Therapeutics – Oxalo Article Snippet: A Round-Up of New Patents and Allowances Oncology Products Onyx Pharmaceuticals, Inc. (Richmond, Cal.) has received U.S. Patent No. 5,801,029, which covers both adenoviruses and other DNA viruses unable to induce synthesis of the proteins that bind to the human retinoblastoma protein, pRb, and ways of using those viruses to treat cancer.. Most cancer cells fail to produce pRb, which ordinarily inhibits progression of cells from the Gl (preparatory) phase of the mitotic cycle to the S (DNA synthesis) phase.. Loss of the active Rb protein thus leads to unrestrained cell multiplication. |